Latest News

 Filter by Provider

Canadians have ways to make their extra income work as hard as they do and say goodbye to financial stress.

Hospitals are consolidating vendors, and Philips is pitching integrated platforms over lowest price, a shift that could define the next contract cycle.

Cerebras bets on giant wafer-scale chips while Nebius sells a full-lifecycle AI cloud, but one valuation gap and a cash flow twist could tip the 2027 verdict.

Investors were reacting to what they considered a lackluster third quarter.

Record AUM growth and raised 2029 targets signal momentum

Deal activity and valuation volume both climbed sharply this quarter.

Braveheart Bio (NASDAQ:BRVE) presented one-year data from a small study of its experimental heart drug BHB-1893 and outlined plans for a fixed-dose trial, as the company advances the treatment through late-stage development for hypertrophic cardiomyopathy. The data, presented with partner Hengrui a

Ardent Health (NYSE:ARDT) raised the lower end of its full-year adjusted EBITDA forecast after reporting $1.62 billion in third-quarter revenue and $138 million in adjusted EBITDA, as lower labor costs and improving patient volumes supported results. The hospital operator now expects 2026 adjusted

Arlo Technologies (NYSE:ARLO) reported higher third-quarter revenue and profitability as its subscription business expanded, and management said it expects to target roughly 30% growth in annual recurring revenue in 2027. Total revenue rose 7% from a year earlier to $149.2 million, including $96 mi

Apple Hospitality REIT (NYSE:APLE) raised its full-year outlook after stronger business and leisure travel drove a 7.3% increase in third-quarter revenue per available room and helped the hotel owner expand its profit margins. Comparable hotel revenue per available room, or RevPAR, reached $134 in

Algonquin Power & Utilities (NYSE:AQN) reported higher adjusted earnings for the third quarter of 2026, supported by favorable weather and new utility rates, and reaffirmed its earnings outlook for this year and next. The company also outlined progress on a proposed Missouri tariff for large-lo

Array Digital Infrastructure (NYSE:AD) reported third-quarter revenue growth driven primarily by its T-Mobile agreement and maintained its full-year outlook, while its parent, TDS, lowered revenue and profit guidance for its fiber business despite record construction and customer additions. The joi

Ameren (NYSE:AEE) raised its 2026 earnings guidance and outlined a $38.1 billion infrastructure investment plan as it prepares for rising electricity demand in Missouri, including from data centers. The utility reported third-quarter earnings of $2.42 per diluted share, up from $2.35 on a generally

ACRES Commercial Realty (NYSE:ACR) reported a third-quarter loss as it absorbed transaction-related charges following its merger and internalization, while executives outlined plans to grow earnings through investment management and insurance. The company reported a GAAP net loss allocable to commo

Ares Commercial Real Estate (NYSE:ACRE) reported third-quarter 2026 net income of $10 million and said it had resolved its only defaulted loan after the quarter ended, as management continued to work through underperforming real estate investments. The commercial real estate lender reported net inc

Advance Auto Parts (NYSE:AAP) reported a decline in third-quarter comparable sales but said trends improved as the period progressed, with professional customers providing growth while household budget pressures continued to weigh on do-it-yourself shoppers. The auto parts retailer reported net sal

Allied Gold (NYSE:AAUC) reported $358 million in third-quarter revenue and said its Kurmuk mine had begun production, setting the stage for a planned increase in gold output and potential shareholder returns in 2027. Chairman and Chief Executive Officer Peter Marrone said ore had entered Kurmuk’s p

Rate volatility is weighing on deal flow, but a looming maturity wave could reshape activity.

Production climbs as the company nears positive free cash flow in 2027.

Reinsurance premiums climbed sharply while persistency stayed elevated.

Record nine-month results and a 2030 growth target already in hand.

It missed badly on third-quarter net income.

Sun Life Financial (TSX:SLF) might be a massive bargain after Thursday's vicious plunge as stock markets sold off hard.

Enbridge’s current dividend needs roughly $42,600 in shares to average $200 monthly, with payments arriving every quarter.

Record NAV and new SBIC capacity marked a steady quarter for the lender.

Acquisition pipeline and Arkansas sale set up the next growth phase.

Insurance income more than doubled as Mount Logan reshaped its fee base.

Aurora-Idaho enters steel installation as fuel and isotope plans advance.

Eli Lilly could thrive even as competition in the weight-loss market intensifies.

A record quarter of investments and a new U.K. expansion drove results.

Management outlines its path back to breakeven as legacy loan resolutions continue.

Management raised 2026 guidance and sees stronger group bookings ahead.

Data center demand lifts capital plan to $25 billion and a higher growth target.

Data center demand is reshaping the utility's growth plans and capital spending outlook.

Delivery volume tripled, yet one platform partner's decline is a point management flagged.

Zai Lab (NASDAQ:ZLAB) reported $108.2 million in third-quarter revenue and said it expects to return to year-over-year product revenue growth in 2027, while advancing its lead cancer drug candidate toward potential U.S. regulatory submissions next year. Founder, CEO and Chairperson Samantha Du said

Air Products and Chemicals (NYSE:APD) forecast adjusted earnings growth of 5% to 8% in fiscal 2027, as the industrial gases company shifts spending toward its core business and works to complete legacy energy transition projects. The outlook followed a fiscal 2026 in which sales rose 8% and adjuste

Eikon Therapeutics (NASDAQ:EIKN) expects an interim analysis of its lead melanoma study in the first half of 2027 and estimates that definitive data from that trial and a lung cancer study could be available around the middle of 2029, CEO Roger Perlmutter said during a JPMorgan biotech call. Both s

Verastem (NASDAQ:VSTM) reported $24 million in third-quarter 2026 net product revenue as refills of its ovarian cancer treatment offset a moderation in new patient starts. The company also outlined plans to begin a late-stage pancreatic cancer trial for its experimental drug VS-7375 by year-end. Re

Alpha Metallurgical Resources (NYSE:AMR) reported higher third-quarter shipments and adjusted earnings, while laying out a 2027 shipping plan that accounts for prolonged repairs at a key export terminal. The metallurgical coal producer shipped 3.9 million tons in the third quarter of 2026, up from

Artivion (NYSE:AORT) reported 9% constant-currency revenue growth in the third quarter of 2026, while adjusted earnings declined as the medical device maker invested in manufacturing and prepared for the U.S. launch of its NEXUS aortic repair system. Revenue rose to $123.8 million, with growth led

Viemed Healthcare (NASDAQ:VMD) reported record third-quarter revenue and higher earnings, as growth in sleep therapy and equipment sales helped the home healthcare provider raise the lower end of its full-year revenue outlook. Revenue rose 12.2% from a year earlier to $80.7 million, while net incom

Verisk Analytics (NASDAQ:VRSK) reported higher third-quarter revenue and adjusted earnings per share as subscription growth and stronger-than-expected transactional revenue helped offset pressure from lighter weather activity and softer property insurance markets. The company maintained its full-ye

Viasat (NASDAQ:VSAT) reported fiscal second-quarter revenue growth driven by its defense business, but said commercial aviation revenue is expected to decline in fiscal 2028 as customer announcements affect part of its business over time. The satellite communications company also said it now expect

VSE (NASDAQ:VSEC) raised its 2026 revenue growth and profitability outlook after reporting record third-quarter results, driven by demand for aircraft engine repairs, acquisition contributions and margin gains in its core aviation business. Revenue rose 91% year over year to $541 million, including

Fee income and niche lines grew as property and energy pullbacks offset gains.

Eagle Ford sale and raised synergy targets shape the quarter's outlook.

The cloud giant maxed out its new four-year fundraising cap in five days. What did it cost shareholders?

Build toward $1,000 a month in tax-free income with a TFSA. See how Enbridge, Scotiabank and ZWC could help, and how much you would need.

LiDAR now drives a fifth of sales in Senstar's record quarter.